9 hrs ago | The Daily Star
Scientific studies can be doctored
Medical news reports and articles are to be approached with an eye of skepticism.
14 hrs ago | The Daily Star
Scientific studies can be doctored
Medical news reports and articles are to be approached with an eye of skepticism.
Scientific studies can be doctored
Medical news reports and articles are to be approached with an eye of skepticism.
Chewing the fat on obesity rankings
The fat rankings are out and Alabama is just behind Mississippi as the fattest state in the union.
Ministers back compensation campaign over arthritis drug Vioxx
A campaign to compensate thousands of British claiming to be victims of a controversial arthritis drug withdrawn after it was linked to heart attacks and strokes has been backed by ministers.
Merck (MRK) higher on Buy rating despite Vioxx settlement news
Merck & Co shares are trading higher today after a Citi Investment Research analyst initiated coverage on the stock with a "Buy" rating , saying the company will benefit as rivals' drug patents expire in the ...
Vioxx settlements will go out soon
NEW JERSEY TRENTON - Merck & Co. will start cutting checks for former users of its withdrawn painkiller Vioxx next month after announcing Thursday that it will fund a $4.85 billion settlement expected to ...
Summary: Key points of Vioxx deal
WHO BENEFITS: Roughly 50,000 former users of Merck's withdrawn painkiller Vioxx, or their survivors, can get a settlement if they suffered a heart attack, stroke, or died and had lawsuits pending when the $4.85 ...
Merck to fund Vioxx settlement in August
Drugmaker Merck & Co. said Thursday it will fund the $4.85 billion settlement expected to resolve roughly 50,000 lawsuits related to its Vioxx painkiller, with initial payments to former users of the withdrawn ...
In Followership , Barbara Kellerman asserts the age of the all-powerful executive has ended.
Save and Protect Lives: Report Gardasil Adverse Reactions to VAERS
Merck, the pharmaceutical giant that withdrew its anti-arthritis drug Vioxx because of increased risk of heart attacks and resulting lawsuits, is now encouraging your teenage girls to receive its new vaccine, ...
A Drug Safety Warning That Could Harm
Ironic, but true -- some doctors are worried about the dangers of the Food and Drug Administration's latest safety effort concerning a class of epilepsy drugs.
Posted online: Thursday , July 10, 2008 at 00:10 hrs Updated On: Thursday , July 10, 2008 at 00:10 hrs Before 1980 the pharmaceutical industry was successful; after 1980 it was "stupendously" successful.
Side effects include suicide and heart attacks. So why are we being prescribed these drugs?
Heart attacks and suicides... yet the dangers were all kept so quiet. So how CAN you trust your medicine? By Jerome Burne Last updated at 9:02 PM on 07th July 2008 A dose of bad medicine? Critics say drugs ...
Inside Medicine: Drugs, placebos and perceptions
Last week, a reader wrote asking why new drugs seem so much more wonderful than they do after they have been on the market for several years.
FDA slowing drugs getting to market
Nearly four years after Merck & Co. yanked the painkiller Vioxx off the market, beleaguered pharmaceutical industry executives say they are facing a tough new regulatory climate that is altering the landscape ...
Safety Officials Get a Seat at the Drug-Regulation Table
Prodded by Congress in the wake of several major drug-safety and effectiveness concerns - starting, perhaps, with Vioxx , and since expanded to several antidepressants, Avandia , Vytorin , Chantrix and others - ...
Compensation demanded over drug
The widow of a man who believes her husband's use of an anti-arthritis drug contributed to his fatal heart attack wants compensation from the drug firm.
More than 59,000 register for Vioxx settlement
More than 59,000 people hope to share in drugmaker Merck & Co.'s settlement of lawsuits claiming injury from the painkiller Vioxx, and administrators have enough records to review about 9,100 of those claims.
A Saskatchewan court decision has certified a national class-action suit that was already pending in Ontario SANDRA RUBIN Sandra Rubin is a contributor to Lexpert; Special to The Globe and Mail When it comes to ...